Prime Therapeutics' Controlled Substance Drug Utilization Review program wins Case In Point Platinum Award in the Disease Management/Population Health category

ST. PAUL, Minn., May 14, 2014 /PRNewswire/ -- Prime Therapeutics, a leading pharmacy benefit manager, won Dorland Health's 2014 Case In Point Platinum Award for the best Disease Management/Population Health program. This annual awards program recognizes the most successful and innovative case management programs in 28 categories across the health care spectrum. Winning programs will be featured in the Case In Point Platinum Award Issue, May 2014 as well as the Platinum Award website.

Judges recognized Prime's Controlled Substance Drug Utilization Review (DUR) program as the best disease management/population health program in the Case Management – Managed Care category. The Controlled Substance DUR program, which is part of Prime's GuidedHealth® platform, helps health plans and physicians identify potential misuse and abuse of controlled substance medications. Doing so helps improve member health and reduce health care costs. The Controlled Substance DUR program has been implemented by most of Prime's clients, including Florida Blue whose positive results were featured in the submission. 

"The Case In Point Platinum Award showcases the value that Prime's Controlled Substance DUR program brings to the health plans and members we serve," said Peter Wickersham, senior vice president, integrated care and specialty. "Prime is dedicated to developing and implementing innovative programs that help improve safety and lower overall cost of care for our members."

The editors of Case In Point conduct the competition to set the standard for sustained success in care coordination programs.  Reviewing submissions from a variety of disciplines and settings, judges looked to honor programs that improved patient education and empowerment, wellness, quality of care management and cost containment.

About Prime Therapeutics
Prime Therapeutics LLC (Prime) helps people get the medicine they need to feel better and live well. Prime manages pharmacy benefits for health plans, employers, and government programs including Medicare and Medicaid. The company processes claims and delivers medicine to members, offering clinical services for people with complex medical conditions. Headquartered in St. Paul, Minn., Prime serves more than 25 million people. It is collectively owned by 13 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those plans. Prime has been recognized as one of the fastest-growing private companies in the nation.

For more information, visit www.primetherapeutics.com or follow @Prime_PBM on Twitter.

SOURCE Prime Therapeutics

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED